Tristan B. Orpin
2015
In 2015, Tristan B. Orpin earned a total compensation of $3.1M as Executive Vice President, Clinical Genomics at Illumina.
Compensation breakdown
| Non-Equity Incentive Plan | $235,041 |
|---|---|
| Salary | $460,381 |
| Stock Awards | $2,300,101 |
| Other | $60,964 |
| Total | $3,056,487 |
Orpin received $2.3M in stock awards, accounting for 75% of the total pay in 2015.
Orpin also received $235K in non-equity incentive plan, $460.4K in salary and $61K in other compensation.
Rankings
In 2015, Tristan B. Orpin's compensation ranked 3,109th out of 13,638 executives tracked by ExecPay. In other words, Orpin earned more than 77.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,109 out of 13,638 | 77th |
Division Manufacturing | 1,108 out of 5,190 | 79th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 134 out of 760 | 82nd |
Industry group Laboratory Apparatus And Analytical, Optical, Measuring, and Controlling Instruments | 42 out of 234 | 82nd |
Industry Laboratory Analytical Instruments | 12 out of 59 | 80th |
Source: SEC filing on April 8, 2016.
Orpin's colleagues
We found four more compensation records of executives who worked with Tristan B. Orpin at Illumina in 2015.